In/FW
vivo/FW
footprinting/NN
and/CC
mutational/JJ
analysis/NN
of/IN
the/DT
proximal/JJ
CD19/NN
promoter/NN
reveal/VBP
important/JJ
roles/NNS
for/IN
an/DT
SP1/Egr-1/NN
binding/NN
site/NN
and/CC
a/DT
novel/JJ
site/NN
termed/VBN
the/DT
PyG/NN
box/NN
./.

CD19/NN
expression/NN
begins/VBZ
at/IN
the/DT
pro-B/JJ
cell/NN
stage/NN
of/IN
B/NN
cell/NN
development/NN
./.
=====
As/IN
such/JJ
it/PRP
serves/VBZ
as/IN
a/DT
good/JJ
prototype/NN
for/IN
B/NN
cell-specific/JJ
genes/NNS
whose/WP$
expression/NN
begins/VBZ
shortly/RB
after/IN
lineage/NN
commitment/NN
./.
=====
To/TO
understand/VB
the/DT
molecular/JJ
mechanisms/NNS
controlling/VBG
CD19/NN
gene/NN
expression/NN
,/,
we/PRP
isolated/VBD
and/CC
functionally/RB
characterized/VBD
the/DT
CD19/NN
promoter/NN
using/VBG
in/FW
vivo/FW
footprinting/NN
,/,
gel/NN
shift/NN
assays/NNS
,/,
and/CC
transfection/NN
studies/NNS
./.
=====
Reporter/NN
constructs/NNS
spanning/VBG
portions/NNS
of/IN
the/DT
promoter/NN
identified/VBD
a/DT
region/NN
between/IN
-85/CD
and/CC
-200/CD
that/WDT
produced/VBD
high/JJ
levels/NNS
of/IN
reporter/NN
gene/NN
activity/NN
in/IN
lymphoid/JJ
cells/NNS
./.
=====
In/FW
vivo/FW
footprinting/NN
identified/VBD
protected/JJ
regions/NNS
over/IN
the/DT
known/JJ
high/JJ
affinity/NN
B/NN
cell/NN
lineage-specific/JJ
activator/NN
protein/NN
(/(
BSAP/NN
)/)
site/NN
,/,
the/DT
low/JJ
affinity/NN
BSAP/NN
site/NN
,/,
a/DT
SP1/Egr-1/NN
site/NN
termed/VBN
the/DT
CD19/NN
GC/NN
box/NN
,/,
and/CC
two/CD
novel/JJ
sites/NNS
named/VBN
the/DT
AT/NN
box/NN
and/CC
PyG/NN
box/NN
./.
=====
Phorbol/NN
ester/NN
treatment/NN
of/IN
a/DT
pre-B/JJ
cell/NN
line/NN
up-regulated/VBD
CD19/NN
expression/NN
,/,
induced/VBD
Egr-1/NN
,/,
and/CC
enhanced/VBD
the/DT
footprint/NN
over/IN
the/DT
GC/NN
box/NN
./.
=====
Gel/NN
shift/NN
assays/NNS
demonstrated/VBD
SP1/NN
and/CC
Egr-1/NN
binding/VBG
to/TO
the/DT
CD19/NN
GC/NN
box/NN
,/,
while/IN
unknown/JJ
nuclear/JJ
proteins/NNS
bound/VBD
the/DT
PyG/NN
and/CC
AT/NN
boxes/NNS
./.
=====
Mutations/NNS
in/IN
the/DT
AT/NN
box/NN
or/CC
in/IN
the/DT
BSAP/NN
sites/NNS
did/VBD
not/RB
affect/VB
CD19/NN
reporter/NN
construct/NN
activity/NN
,/,
while/IN
a/DT
mutation/NN
of/IN
the/DT
GC/NN
box/NN
reduced/VBD
it/PRP
modestly/RB
,/,
and/CC
a/DT
PyG/NN
box/NN
mutation/NN
reduced/VBD
it/PRP
dramatically/RB
./.
=====
BSAP/NN
failed/VBD
to/TO
trans-activate/VB
CD19/NN
promoter/NN
constructs/NNS
in/IN
B/NN
cells/NNS
or/CC
non-B/JJ
cells/NNS
,/,
suggesting/VBG
that/IN
cis/JJ
elements/NNS
such/JJ
as/IN
the/DT
PyG/NN
and/CC
GC/NN
boxes/NNS
are/VBP
also/RB
necessary/JJ
for/IN
high/JJ
level/NN
CD19/NN
promoter/NN
expression/NN
./.